Zhejiang East-Asia Pharmaceutical (605177.SH) announced that the fourth board of directors meeting will be held on December 6, 2024...
According to the report from Zhitong Finance APP, Zhejiang East-Asia Pharmaceutical (605177.SH) announced that during the third meeting of the fourth board of directors and the third meeting of the fourth supervisory board held on December 6, 2024, the proposal "Regarding the Grant of Restricted Stocks to the Incentive Objects of the 2024 Restricted Stock Incentive Plan" was reviewed and approved, determining December 6, 2024, as the grant date, with a grant price of 9.47 yuan/share, granting 2.170103 million shares of restricted stocks to 152 incentive objects.